| Q37074302 | APOE polymorphisms influence longitudinal lipid trends preceding intracerebral hemorrhage |
| Q35184834 | Age-related white matter changes |
| Q37416066 | Apolipoprotein E, statins, and risk of intracerebral hemorrhage |
| Q41869091 | Association between Low-density lipoprotein cholesterol and occipital periventricular hyperintensities in a group of Chinese patients: an observational study |
| Q35015568 | Association between statin use and intracerebral hemorrhage: a systematic review and meta-analysis |
| Q64228297 | Association of Apolipoprotein E With Intracerebral Hemorrhage Risk by Race/Ethnicity: A Meta-analysis |
| Q36237971 | Characteristics of subjects with very low serum low-density lipoprotein cholesterol and the risk for intracerebral hemorrhage |
| Q85110733 | Deep White Matter Hyperintensities, Decreased Serum Low-Density Lipoprotein, and Dilative Large Arteriopathy |
| Q35098225 | Genetic epidemiology of intracerebral hemorrhage |
| Q37208520 | Hyperlipidemia and reduced white matter hyperintensity volume in patients with ischemic stroke |
| Q48681003 | Hyperperfusion syndrome after supraaortic vessel interventions and bypass surgery. |
| Q50798013 | Intracerebral haemorrhage in a population-based stroke registry (LuSSt): incidence, aetiology, functional outcome and mortality. |
| Q48966082 | Intracerebral hemorrhage: effective therapy at last? |
| Q33579357 | Low cholesterol level associated with severity and outcome of spontaneous intracerebral hemorrhage: Results from Taiwan Stroke Registry |
| Q40478290 | Management of Primary Hypertensive Hemorrhage of the Brain. |
| Q36022209 | New era for management of primary hypertensive intracerebral hemorrhage |
| Q51924177 | Risk factors for primary intracerebral hemorrhage: a population-based nested case-control study. |
| Q33671008 | Sex Differences in the Clinical Features, Risk Factors, and Outcomes of Intracerebral Hemorrhage: a Large Hospital-based Stroke Registry in China |
| Q24603957 | Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism |
| Q81623503 | Statins and stroke |
| Q48171450 | Statins do not increase Markers of Cerebral Angiopathies in patients with Cardioembolic Stroke. |
| Q45078529 | Statins for treatment of CNS diseases. Status report from research and clinical practice |
| Q37907293 | Statins in hemorrhagic stroke |
| Q36963300 | Subacute decline in serum lipids precedes the occurrence of primary intracerebral hemorrhage |
| Q38673887 | The Role of Statin Therapy in Hemorrhagic Stroke |
| Q37739315 | The role of statins in neurosurgery |
| Q34411415 | Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis |
| Q36471101 | Update on intracerebral haemorrhage |
| Q34477641 | White Matter Hyperintensity Burden and Susceptibility to Cerebral Ischemia |
| Q80001271 | [Recommendations of the European Stroke Initiative for the diagnosis and treatment of spontaneous intracerebral haemorrhage] |